This study is in progress, not accepting new patients
Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at California City, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Cosmo Technologies Ltd
- Links
- National Cancer Institute. Cancer of the Esophagus - SEER Stat Fact Sheets [Internet]. Cancer Statistics. 2015 [cited 2015 Sep 15]. International Council on Harmonisation. Addendum to ICH E11: Clinical Investigation of Medicinal Products in the Pediatric Population e11(r1). Vol. Step 4, ICH Harmonised Guideline E11 (R1). 2017. International Conference on Harmonization Guidance on Good Clinical Practice [Internet]. [cited 2016 Jan 1].
- ID
- NCT03863145
- Phase
- Phase 1 Solid Tumor Research Study
- Study Type
- Interventional
- Participants
- Expecting 90 study participants
- Last Updated